Moreover, IL-22 levels were positively correlated with disease severity as measured by the PASI, supporting the notion that IL-22 expression is not merely a bystander phenomenon but may play an active role in the pathogenesis of psoriasis. This evidence concerns the gene IL22 and psoriasis.